CD8A and neoplasm: Co-linearly, YUMM2.1 P3 cells showed a decrease in the overall number of overall CD8+ T cells and tumor-reactive CD8+ T cells and an increase in the percentage of apoptotic tumor cells compared with YUMM2.1 P0 cells (Supplemental Figure 5, B–D).